Skip to main content
Log in

Evaluation of photodynamic therapy in gastric cancer

  • Published:
Lasers in Medical Science Aims and scope Submit manuscript

Abstract

Twenty-eight patients with gastric cancer were treated by photodynamic therapy. Haematoporphyrin derivative was used as a photosensitizer and an argon dye laser as a light source. Histologically, all tumours were adenocarcinomas. On the basis of endoscopy, 17 cases were categorized as early-stage cancer and were classified as type IIc (10 lesions), Ha (three lesions), combined type IIc and type III (three lesions) and type I (two lesions). In 11 patients with advanced-stage cancer, endoscopy showed one case of Borrmann I, three of Borrmann II, six of Borrmann III and a single case of Borrmann IV. In the 17 patients with early-stage cancers (18 lesions), complete remission was obtained in 10 patients (11 lesions). Of 13 resected cancers complete remission was confirmed in six lesions on the basis of detailed histological examination of resected specimens. In the advanced stage tumours all 11 patients showed incomplete remissions. It is considered that an incomplete response in the early-stage cancers is due to insufficient light dosage because of the wide area of tumour, because the site of the lesion is anatomically difficult to photoradiate and because the invasion extends to the muscular layer and serosa.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Tappeiner H, Jesionek A. Therapeutische Versuche mit fluoreszierenden Stoffe.Muench Med Wochenschr 1903,1:2042–4

    Google Scholar 

  2. Lipson RL, Baldes EJ. The photodynamic properties of a particular hematoporphyrin derivative.Arch Dermatol 1960,82:508–16

    PubMed  Google Scholar 

  3. Gomer CJ, Doiron DR, Rucker N et al. Examination of action spectrum, dose rate and mutagenic properties of hematoporphyrin derivative in photoradiation therapy. In: Doiron DR, Gomer CJ (eds)Porphyrin localization and treatment of tumors. New York: Alan R. Liss Inc. (Prog Clin Biol Res 170) 1984:459–69

    Google Scholar 

  4. Dougherty TJ, Grindey GB, Weishaupt KR, Boyle D. Photoradiation therapy. II: Cure of animal tumors with hematoporphyrin and light.J Natl Cancer Inst 1975,55:115–21

    PubMed  Google Scholar 

  5. Dougherty TJ, Kaufman JE, Goldfalb A et al. Photoradiation therapy for the treatment of malignant tumors.Cancer Res 1978,38:2628–35

    PubMed  Google Scholar 

  6. Hayata Y, Kato H, Konaka C et al. Fiberoptic bronchoscopic photoradiation in experimentally induced canine lung cancer.Cancer (Phila) 1983,51:50–6

    Google Scholar 

  7. Kato H, Konaka C, Ono J et al. Effectiveness of HpD and radiation therapy in lung cancer. In: Kessel D, Dougherty TJ (eds)Porphyrin photosensitization. New York: Plenum (Adv Exp Med Biol 160) 1983:23–9

    Google Scholar 

  8. Hayata Y, Kato H, Konaka C et al. Hematoporphyrin derivative and laser photoradiation in the treatment of lung cancer.Chest 1982,81:269–77

    PubMed  Google Scholar 

  9. Definition of early carcinoma of the stomach. Editorial.I To Cho (Stomach Intest) 1982,17:8

    Google Scholar 

  10. Hayata Y, Dougherty TJ.Lasers and hematoporphyrin derivative in cancer. Tokyo: Igaku-Shoin, 1983

    Google Scholar 

  11. Figge FHJ, Weiland GS, Manganiello LOJ. Cancer detection and therapy. Affinity of neoplastic, embryonic, and traumatized tissues for porphyrins and metallo-porphyrins.Proc Soc Exp Biol Med 1948,68:640–1

    Google Scholar 

  12. Sanderson DR, Fontana RS, Lipson RL, Baldes EJ. Hematoporphyrin as a diagnostic tool. A preliminary report of new techniques.Cancer (Phila) 1972,30:1368–72

    Google Scholar 

  13. Tomson SH, Emmett EA, Fox SH. Photodestruction of mouse epithelial tumors after oral acridine orange and argon laser.Cancer Res 1974,34:3124–6

    PubMed  Google Scholar 

  14. Otawa M, Aizawa K, Kato H et al. Basic study concerning tissue penetration of laser beam.Gendai-No-Shinryo 1982,24:25–9

    Google Scholar 

  15. Weishaupt KR, Gomer CJ, Dougherty TJ. Identification of singlet oxygen as the cytotoxic agent in photoinactivation of a murine tumor.Cancer Res 1976,36:2326–9

    PubMed  Google Scholar 

  16. Sakai H, Aizawa K, Kato H, Hayata Y. Detection of singlet oxygen from HpD using luminol.J Tokyo Med Coll 43:6 (in press)

  17. Kessel D. Effects of photoactivated porphyrins at the cell surface of leukemia L1210 cells.Biochemistry 1977,16:3443–9

    Article  PubMed  Google Scholar 

  18. Moan J, Steen HB, Ferer K, Christensen T. Uptake of hematoporphyrin derivative in cells of different oncogenic potential.Cancer Lett 1981,14:291–6

    Article  PubMed  Google Scholar 

  19. Saito M, Kato H, Konaka C et al. Affinity of HpD for mitochondriaIgaku-No-Ayumi 1985,132:600–2

    Google Scholar 

  20. Kato H, Aizawa K, Shinohara H et al. Cytomorphological changes caused by hematoporphyrin derivative and photodynamic therapy.Lasers in the Life Sciences (in press)

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kato, H., Kawaguchi, M., Konaka, C. et al. Evaluation of photodynamic therapy in gastric cancer. Laser Med Sci 1, 67–74 (1986). https://doi.org/10.1007/BF02030738

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02030738

Key words

Navigation